Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia

被引：3
|
作者：
Beauclair, L
Lam, A
McCormick, J
Luong, D
Camacho, F
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67769-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A202 / A203
页数：2
相关论文
共 50 条
  • [1] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [2] Hospitalization and medication use in schizophrenia patients receiving risperidone long-acting injectable or oral atypical antipsychotic medication
    Chue, P.
    Lam, A.
    Chandra, K.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [3] Hospitalization and medication use in schizophrenia patients receiving risperidone long-acting injectable or oral atypical antipsychotic medication
    Chue, P
    Lam, A
    Chandra, K
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A202
  • [4] Long-acting injectable risperidone for the treatment of schizophrenia
    Moeller, Hans-Juergen
    DRUGS, 2007, 67 (11) : 1541 - 1566
  • [5] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Kim, H.
    Hong, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S456
  • [6] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Ciwoniuk, M.
    Godlewska, B. R.
    Olajossy-Hilkesberger, L.
    Olajossy, M.
    Marmurowska-Michalowska, H.
    Limon, J.
    Landowski, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S457
  • [7] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
  • [8] Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia
    Kim, Sung-Wan
    Kim, Ki-Min
    Kim, Jae-Min
    Shin, Il-Seon
    Shin, Hee-Young
    Yang, Su-Jin
    Yoon, Jin-Sang
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (02): : 543 - 545
  • [9] Neurocognition and attitudes to medication in risperidone long-acting injectable
    Penades, R.
    Catalan, R.
    Pujol, N.
    Navarro, V.
    Massana, G.
    Gasto, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S462 - S463
  • [10] Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
    Louza, Mario Rodrigues
    Elkis, Helio
    Ruschel, Sandra
    de Oliveira, Irismar Reis
    Bressan, Rodrigo Affonseca
    Belmonte-de-Abreu, Paulo
    Grabowski, Hamilton
    Appolinario, Jose Carlos
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 391 - 398
12345